Anti-tumor immunity induced by murine melanoma cells transduced with the Mycobacterium tuberculosis gene encoding the 38-kDa antigen

[1]  H. Vordermeier,et al.  Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. , 1997, Journal of immunology.

[2]  P. Musiani,et al.  Cytokines, tumour-cell death and immunogenicity: a question of choice. , 1997, Immunology today.

[3]  T. Schweighoffer.  Tumor cells expressing a recall antigen are powerful cancer vaccines , 1996, European journal of immunology.

[4]  Pardoll.  Cancer vaccines: a road map for the next decade. , 1996, Current opinion in immunology.

[5]  G. Strassmann,et al.  Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101. , 1996, Journal of the National Cancer Institute.

[6]  P. Musiani,et al.  IL‐1α gene‐transfected human melanoma cells increase tumor‐cell adhesion to endothelial cells and their retention in the lung of nude mice , 1996 .

[7]  Donna L. Montgomery,et al.  Immunogenicity and protective efficacy of a tuberculosis DNA vaccine , 1996, Nature Medicine.

[8]  P. Srivastava,et al.  Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors. , 1995, Seminars in cancer biology.

[9]  E. Dratz,et al.  Studies of the structure of the metastasis-associated 67 kDa laminin binding protein: fatty acid acylation and evidence supporting dimerization of the 32 kDa gene product to form the mature protein. , 1995, Biochemistry.

[10]  G. Rook,et al.  Tuberculosis and cancer: parallels in host responses and therapeutic approaches? , 1995, The Lancet.

[11]  F. Garrido,et al.  HLA class I antigens in human tumors. , 1995, Advances in cancer research.

[12]  F. Hartl,et al.  Molecular chaperones in cellular protein folding. , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[13]  P. Matzinger.  Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[14]  K. Lukacs,et al.  Tumor cells transfected with a bacterial heat-shock gene lose tumorigenicity and induce protection against tumors , 1993, The Journal of experimental medicine.

[15]  K. Timmis,et al.  The Mycobacterium tuberculosis 38-kDa antigen: overproduction in Escherichia coli, purification and characterization. , 1992, Gene.

[16]  H. Vordermeier,et al.  M. tuberculosis‐Complex Specific T‐Cell Stimulation and DTH Reactions Induced With a Peptide from the 38‐kDa Protein , 1992, Scandinavian journal of immunology.

[17]  S. Russell,et al.  Immunity to B16 melanoma in mice immunized with IL‐2‐secreting allogeneic mouse fibroblasts expressing melanoma‐associated antigens , 1992, International journal of cancer.

[18]  M. Colombo,et al.  Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo , 1991, The Journal of experimental medicine.

[19]  D. Young,et al.  Lipoprotein antigens ofMycobacterium tuberculosis , 1991 .

[20]  D. Young,et al.  Lipoprotein antigens of Mycobacterium tuberculosis. , 1991, Research in microbiology.

[21]  J. Bishop.  Retroviruses and Oncogenes II (Nobel Lecture) , 1990 .

[22]  J. Grange,et al.  BCG vaccination and cancer. , 1990, Tubercle.

[23]  S. Goff,et al.  Construction and use of a safe and efficient amphotropic packaging cell line. , 1988, Virology.

[24]  S. Goff,et al.  A safe packaging line for gene transfer: separating viral genes on two different plasmids , 1988, Journal of virology.

[25]  S. Silagi,et al.  Efficient DNA-mediated transfer of selectable genes and unselected sequences into differentiated and undifferentiated mouse melanoma clones , 1984, Somatic cell and molecular genetics.

[26]  I. Fidler,et al.  The pathogenesis of cancer metastasis , 1980, Nature.